478 related articles for article (PubMed ID: 21729665)
1. ALK-1-negative anaplastic large cell lymphoma associated with breast implants: a new clinical entity.
Lazzeri D; Agostini T; Bocci G; Giannotti G; Fanelli G; Naccarato AG; Danesi R; Tuccori M; Pantaloni M; D'Aniello C
Clin Breast Cancer; 2011 Oct; 11(5):283-96. PubMed ID: 21729665
[TBL] [Abstract][Full Text] [Related]
2. [Breast implants and anaplastic large cell lymphoma: What do we know?].
Mychaluk J; Perignon D; Qassemyar Q; Gianfermi M; Sinna R
Ann Chir Plast Esthet; 2012 Feb; 57(1):1-8. PubMed ID: 22243720
[TBL] [Abstract][Full Text] [Related]
3. Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes.
Laurent C; Delas A; Gaulard P; Haioun C; Moreau A; Xerri L; Traverse-Glehen A; Rousset T; Quintin-Roue I; Petrella T; Emile JF; Amara N; Rochaix P; Chenard-Neu MP; Tasei AM; Menet E; Chomarat H; Costes V; Andrac-Meyer L; Michiels JF; Chassagne-Clement C; de Leval L; Brousset P; Delsol G; Lamant L
Ann Oncol; 2016 Feb; 27(2):306-14. PubMed ID: 26598546
[TBL] [Abstract][Full Text] [Related]
4. Anaplastic large-cell lymphoma in women with breast implants.
de Jong D; Vasmel WL; de Boer JP; Verhave G; Barbé E; Casparie MK; van Leeuwen FE
JAMA; 2008 Nov; 300(17):2030-5. PubMed ID: 18984890
[TBL] [Abstract][Full Text] [Related]
5. Anaplastic large cell lymphoma, ALK-negative.
Ferreri AJ; Govi S; Pileri SA; Savage KJ
Crit Rev Oncol Hematol; 2013 Feb; 85(2):206-15. PubMed ID: 22789917
[TBL] [Abstract][Full Text] [Related]
6. Anaplastic large cell lymphoma (ALCL) and breast implants: breaking down the evidence.
Ye X; Shokrollahi K; Rozen WM; Conyers R; Wright P; Kenner L; Turner SD; Whitaker IS
Mutat Res Rev Mutat Res; 2014; 762():123-32. PubMed ID: 25475421
[TBL] [Abstract][Full Text] [Related]
7. Risk of lymphoma in women with breast implants: analysis of clinical studies.
Largent J; Oefelein M; Kaplan HM; Okerson T; Boyle P
Eur J Cancer Prev; 2012 May; 21(3):274-80. PubMed ID: 22456426
[TBL] [Abstract][Full Text] [Related]
8. Clusterin is widely expressed in systemic anaplastic large cell lymphoma but fails to differentiate primary from secondary cutaneous anaplastic large cell lymphoma.
Lae ME; Ahmed I; Macon WR
Am J Clin Pathol; 2002 Nov; 118(5):773-9. PubMed ID: 12428799
[TBL] [Abstract][Full Text] [Related]
9. Anaplastic large cell lymphoma associated with a breast implant capsule: a case report and review of the literature.
Wong AK; Lopategui J; Clancy S; Kulber D; Bose S
Am J Surg Pathol; 2008 Aug; 32(8):1265-8. PubMed ID: 18594466
[TBL] [Abstract][Full Text] [Related]
10. Breast implant-associated anaplastic large cell lymphoma: review of a distinct clinicopathologic entity.
Xu J; Wei S
Arch Pathol Lab Med; 2014 Jun; 138(6):842-6. PubMed ID: 24878027
[TBL] [Abstract][Full Text] [Related]
11. Anaplastic large cell lymphoma involving the breast: a clinicopathologic study of 6 cases and review of the literature.
Miranda RN; Lin L; Talwalkar SS; Manning JT; Medeiros LJ
Arch Pathol Lab Med; 2009 Sep; 133(9):1383-90. PubMed ID: 19722744
[TBL] [Abstract][Full Text] [Related]
12. Lymphomas Associated with Breast Implants: A Review of the Literature.
Rupani A; Frame JD; Kamel D
Aesthet Surg J; 2015 Jul; 35(5):533-44. PubMed ID: 26116741
[TBL] [Abstract][Full Text] [Related]
13. Anaplastic lymphoma kinase (ALK) positive anaplastic large cell lymphoma (ALCL) of breast in a patient without a breast implant.
Sathyanarayanan V; Lokesh KN; Lakshmaiah KC; Govind Babu K; Lokanatha D; Suresh Babu MC; Rao CR; Chennagiri P
Ann Saudi Med; 2014; 34(6):551-4. PubMed ID: 25971833
[TBL] [Abstract][Full Text] [Related]
14. Survival signals and targets for therapy in breast implant-associated ALK--anaplastic large cell lymphoma.
Lechner MG; Megiel C; Church CH; Angell TE; Russell SM; Sevell RB; Jang JK; Brody GS; Epstein AL
Clin Cancer Res; 2012 Sep; 18(17):4549-59. PubMed ID: 22791880
[TBL] [Abstract][Full Text] [Related]
15. Breast implant-associated ALK-negative anaplastic large cell lymphoma: a case report and discussion of possible pathogenesis.
George EV; Pharm J; Houston C; Al-Quran S; Brian G; Dong H; Hai W; Reeves W; Yang LJ
Int J Clin Exp Pathol; 2013; 6(8):1631-42. PubMed ID: 23923082
[TBL] [Abstract][Full Text] [Related]
16. Cytological Diagnosis of Bilateral Breast Implant-Associated Lymphoma of the ALK-Negative Anaplastic Large-Cell Type. Clinical Implications of Peri-Implant Breast Seroma Cytological Reporting.
Granados R; Lumbreras EM; Delgado M; Aramburu JA; Tardío JC
Diagn Cytopathol; 2016 Jul; 44(7):623-7. PubMed ID: 27079579
[TBL] [Abstract][Full Text] [Related]
17. Detection of a subset of CD30+ anaplastic large cell lymphoma by interphase fluorescence in situ hybridization.
Shin HJ; Thorson P; Gu J; Katz RL
Diagn Cytopathol; 2003 Aug; 29(2):61-6. PubMed ID: 12889041
[TBL] [Abstract][Full Text] [Related]
18. Flow cytometry of ALK-negative anaplastic large cell lymphoma of breast implant-associated effusion and capsular tissue.
Wu D; Allen CT; Fromm JR
Cytometry B Clin Cytom; 2015 Jan; 88(1):58-63. PubMed ID: 25044944
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of MUC-1 expression in systemic anaplastic large cell lymphoma.
Rassidakis GZ; Goy A; Medeiros LJ; Jiang Y; Thomaides A; Remache Y; Cabanillas F; Sarris AH; Gilles F
Clin Cancer Res; 2003 Jun; 9(6):2213-20. PubMed ID: 12796388
[TBL] [Abstract][Full Text] [Related]
20. Anaplastic large T-cell lymphoma and breast implants: a review of the literature.
Jewell M; Spear SL; Largent J; Oefelein MG; Adams WP
Plast Reconstr Surg; 2011 Sep; 128(3):651-661. PubMed ID: 21865998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
